TP53 and non-small cell lung carcinoma: Given that TRRUST analysis implicated RELA (p65) as a key transcription factor influenced by TP53-GOF mutation and osimertinib treatment in EGFR-mutated NSCLC cells, we examined the binding of p65 to the promoter region of the TNF gene by ChIP-qPCR analysis.